Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-12.20%
↓ 69% below average
Average (34q)
-7.22%
Historical baseline
Range
High:36.84%
Low:-52.00%
Volatility
-1230.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -12.20% |
| Q2 2025 | -18.27% |
| Q1 2025 | -18.18% |
| Q4 2024 | 8.33% |
| Q3 2024 | -2.13% |
| Q2 2024 | -1.08% |
| Q1 2024 | -4.49% |
| Q4 2023 | 11.88% |
| Q3 2023 | -7.45% |
| Q2 2023 | -14.63% |
| Q1 2023 | -3.80% |
| Q4 2022 | -5.33% |
| Q3 2022 | 5.06% |
| Q2 2022 | -5.33% |
| Q1 2022 | -10.29% |
| Q4 2021 | 6.85% |
| Q3 2021 | -4.29% |
| Q2 2021 | -1.45% |
| Q1 2021 | -4.55% |
| Q4 2020 | -17.86% |
| Q3 2020 | -5.66% |
| Q2 2020 | 25.35% |
| Q1 2020 | -18.33% |
| Q4 2019 | 0.00% |
| Q3 2019 | -17.65% |
| Q2 2019 | -37.84% |
| Q1 2019 | -5.71% |
| Q4 2018 | 7.89% |
| Q3 2018 | -52.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -38.89% |
| Q4 2017 | -5.88% |
| Q3 2017 | -41.67% |
| Q2 2017 | 36.84% |
| Q1 2017 | 0.00% |